EUVIMEDEUVIMED entdecken
Crossref

The improvement of intestinal dysbiosis and hepatic metabolic dysfunction in dextran sulfate sodium‐induced colitis mice: effects of curcumin

Feini Zhou iD, Ting Mai, Ziren Wang, Zhaolong Zeng, Jingjing Shi, Fan Zhang, Ning Kong, Hao Jiang, Lingnan Guo, Maosheng Xu iD, Jiangnan Lin iD

Journal of Gastroenterology and Hepatology · 2023

DOI: 10.1111/jgh.16205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Feini Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Curcumin, Colitis, Inflammatory Bowel Diseases, Liver Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Medicine Research Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Curcumin may have promising application in the prevention and amelioration of inflammatory bowel disease (IBD). However, the underlying mechanisms underpinning the ability of curcumin to interact with the gut and liver in IBD remains to be defined, which is the exploration aim of this study.

Methods

Mice with dextran sulfate sodium salt (DSS)‐induced acute colitis were treated either with 100 mg/kg of curcumin or phosphate buffer saline (PBS). Hematoxylin–eosin (HE) staining, 16S rDNA Miseq sequencing, proton nuclear magnetic resonance ( 1 H NMR) spectroscopy, and liquid chromatography–tandem mass spectrometry (LC‐MS/MS) were applied for analysis. Spearman's correlation coefficient (SCC) was utilized to assess the correlation between the modification of intestinal bacteria and hepatic metabolite parameters.

Results

Curcumin supplementation not only prevented further loss of body weight and colon length in IBD mice but also improved diseases activity index (DAI), colonic mucosal injury, and inflammatory infiltration. Meanwhile, curcumin restored the composition of the gut microbiota, significantly increased Akkermansia , Muribaculaceae_unclassified , and Muribaculum , and significantly elevated the concentration of propionate, butyrate, glycine, tryptophan, and betaine in the intestine. For hepatic metabolic disturbances, curcumin intervention altered 14 metabolites, including anthranilic acid and 8‐amino‐7‐oxononanoate while enriching pathways related to the metabolism of bile acids, glucagon, amino acids, biotin, and butanoate. Furthermore, SCC analysis revealed a potential correlation between the upregulation of intestinal probiotics and alterations in liver metabolites.

Conclusion

The therapeutic mechanism of curcumin against IBD mice occurs by improving intestinal dysbiosis and liver metabolism disorders, thus contributing to the stabilization of the gut–liver axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminColitisInflammatory Bowel DiseasesLiver DiseasesAnimalsMiceDextran SulfateDysbiosisChromatography, LiquidTandem Mass SpectrometryColonMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

CurcuminGut microbiotaInflammatory bowel diseaseLiverMetabolites

Substanzen

CurcuminDextran Sulfate

Autor:innen und Institutionen

  • The First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
  • The Third School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, China.
  • Key Laboratory of Digestive Pathophysiology of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang, Hangzhou, 310006, China.

ORCID-Profile: Feini Zhou, Maosheng Xu, Jiangnan Lin

Förderung

  • National Natural Science Foundation of China
  • Chinese Medicine Research Program of Zhejiang Province

Zitieren

APA

Zhou, F., Mai, T., Wang, Z., Zeng, Z., Shi, J., Zhang, F., Kong, N., Jiang, H., Guo, L., Xu, M., & Lin, J. (2023). The improvement of intestinal dysbiosis and hepatic metabolic dysfunction in dextran sulfate sodium‐induced colitis mice: effects of curcumin. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16205

Vancouver

Zhou F, Mai T, Wang Z, Zeng Z, Shi J, Zhang F, et al. The improvement of intestinal dysbiosis and hepatic metabolic dysfunction in dextran sulfate sodium‐induced colitis mice: effects of curcumin. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16205

BibTeX
@article{Zhou2023,
  author = {Zhou, Feini and Mai, Ting and Wang, Ziren and Zeng, Zhaolong and Shi, Jingjing and Zhang, Fan and Kong, Ning and Jiang, Hao and Guo, Lingnan and Xu, Maosheng and Lin, Jiangnan},
  title = {The improvement of intestinal dysbiosis and hepatic metabolic dysfunction in dextran sulfate sodium‐induced colitis mice: effects of curcumin},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1111/jgh.16205}
}
Kostenlos starten →